: These Israeli pharmaceutical stocks are down in the wake of Hamas attack

Shares of Israeli pharmaceutical giant Teva are down in premarket trades Monday following Hamas’ surprise attack over the weekend.

Previous post : Alnylam to scrap sNDA for patisiran after receiving FDA complete response letter
Next post : Good for stocks? Why Tom Lee says the attack on Israel may help equities